Cargando…

Medicinal Use of Testosterone and Related Steroids Revisited

Testosterone derivatives and related compounds (such as anabolic-androgenic steroids—AAS) are frequently misused by athletes (both professional and amateur) wishing to promote muscle development and strength or to cover AAS misuse. Even though these agents are vastly regarded as abusive material, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Tauchen, Jan, Jurášek, Michal, Huml, Lukáš, Rimpelová, Silvie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919692/
https://www.ncbi.nlm.nih.gov/pubmed/33672087
http://dx.doi.org/10.3390/molecules26041032
_version_ 1783658174541201408
author Tauchen, Jan
Jurášek, Michal
Huml, Lukáš
Rimpelová, Silvie
author_facet Tauchen, Jan
Jurášek, Michal
Huml, Lukáš
Rimpelová, Silvie
author_sort Tauchen, Jan
collection PubMed
description Testosterone derivatives and related compounds (such as anabolic-androgenic steroids—AAS) are frequently misused by athletes (both professional and amateur) wishing to promote muscle development and strength or to cover AAS misuse. Even though these agents are vastly regarded as abusive material, they have important pharmacological activities that cannot be easily replaced by other drugs and have therapeutic potential in a range of conditions (e.g., wasting syndromes, severe burns, muscle and bone injuries, anemia, hereditary angioedema). Testosterone and related steroids have been in some countries treated as controlled substances, which may affect the availability of these agents for patients who need them for therapeutic reasons in a given country. Although these agents are currently regarded as rather older generation drugs and their use may lead to serious side-effects, they still have medicinal value as androgenic, anabolic, and even anti-androgenic agents. This review summarizes and revisits the medicinal use of compounds based on the structure and biological activity of testosterone, with examples of specific compounds. Additionally, some of the newer androgenic-anabolic compounds are discussed such as selective androgen receptor modulators, the efficacy/adverse-effect profiles of which have not been sufficiently established and which may pose a greater risk than conventional androgenic-anabolic agents.
format Online
Article
Text
id pubmed-7919692
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79196922021-03-02 Medicinal Use of Testosterone and Related Steroids Revisited Tauchen, Jan Jurášek, Michal Huml, Lukáš Rimpelová, Silvie Molecules Review Testosterone derivatives and related compounds (such as anabolic-androgenic steroids—AAS) are frequently misused by athletes (both professional and amateur) wishing to promote muscle development and strength or to cover AAS misuse. Even though these agents are vastly regarded as abusive material, they have important pharmacological activities that cannot be easily replaced by other drugs and have therapeutic potential in a range of conditions (e.g., wasting syndromes, severe burns, muscle and bone injuries, anemia, hereditary angioedema). Testosterone and related steroids have been in some countries treated as controlled substances, which may affect the availability of these agents for patients who need them for therapeutic reasons in a given country. Although these agents are currently regarded as rather older generation drugs and their use may lead to serious side-effects, they still have medicinal value as androgenic, anabolic, and even anti-androgenic agents. This review summarizes and revisits the medicinal use of compounds based on the structure and biological activity of testosterone, with examples of specific compounds. Additionally, some of the newer androgenic-anabolic compounds are discussed such as selective androgen receptor modulators, the efficacy/adverse-effect profiles of which have not been sufficiently established and which may pose a greater risk than conventional androgenic-anabolic agents. MDPI 2021-02-15 /pmc/articles/PMC7919692/ /pubmed/33672087 http://dx.doi.org/10.3390/molecules26041032 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tauchen, Jan
Jurášek, Michal
Huml, Lukáš
Rimpelová, Silvie
Medicinal Use of Testosterone and Related Steroids Revisited
title Medicinal Use of Testosterone and Related Steroids Revisited
title_full Medicinal Use of Testosterone and Related Steroids Revisited
title_fullStr Medicinal Use of Testosterone and Related Steroids Revisited
title_full_unstemmed Medicinal Use of Testosterone and Related Steroids Revisited
title_short Medicinal Use of Testosterone and Related Steroids Revisited
title_sort medicinal use of testosterone and related steroids revisited
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919692/
https://www.ncbi.nlm.nih.gov/pubmed/33672087
http://dx.doi.org/10.3390/molecules26041032
work_keys_str_mv AT tauchenjan medicinaluseoftestosteroneandrelatedsteroidsrevisited
AT jurasekmichal medicinaluseoftestosteroneandrelatedsteroidsrevisited
AT humllukas medicinaluseoftestosteroneandrelatedsteroidsrevisited
AT rimpelovasilvie medicinaluseoftestosteroneandrelatedsteroidsrevisited